ATE250932T1 - Verfahren zur behandlung von chronischem schmerz durch verabreichung von einem mek hemmer - Google Patents
Verfahren zur behandlung von chronischem schmerz durch verabreichung von einem mek hemmerInfo
- Publication number
- ATE250932T1 ATE250932T1 AT00945140T AT00945140T ATE250932T1 AT E250932 T1 ATE250932 T1 AT E250932T1 AT 00945140 T AT00945140 T AT 00945140T AT 00945140 T AT00945140 T AT 00945140T AT E250932 T1 ATE250932 T1 AT E250932T1
- Authority
- AT
- Austria
- Prior art keywords
- administration
- chronic pain
- treating chronic
- mek inhibitor
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14465999P | 1999-07-16 | 1999-07-16 | |
US14428099P | 1999-07-16 | 1999-07-16 | |
US14465599P | 1999-07-16 | 1999-07-16 | |
US14441999P | 1999-07-16 | 1999-07-16 | |
US14432099P | 1999-07-16 | 1999-07-16 | |
US14465899P | 1999-07-16 | 1999-07-16 | |
PCT/US2000/018348 WO2001005393A2 (en) | 1999-07-16 | 2000-07-05 | Method for treating chronic pain using mek inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE250932T1 true ATE250932T1 (de) | 2003-10-15 |
Family
ID=27558291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00945140T ATE250932T1 (de) | 1999-07-16 | 2000-07-05 | Verfahren zur behandlung von chronischem schmerz durch verabreichung von einem mek hemmer |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1202724B1 (de) |
JP (1) | JP2003504401A (de) |
KR (1) | KR20020016899A (de) |
CN (1) | CN1365277A (de) |
AT (1) | ATE250932T1 (de) |
AU (1) | AU5912500A (de) |
CA (1) | CA2378381A1 (de) |
DE (1) | DE60005688T2 (de) |
DK (1) | DK1202724T3 (de) |
ES (1) | ES2208364T3 (de) |
HK (1) | HK1047895A1 (de) |
HU (1) | HUP0202180A3 (de) |
IL (1) | IL147618A0 (de) |
PL (1) | PL352712A1 (de) |
PT (1) | PT1202724E (de) |
TR (1) | TR200200205T2 (de) |
WO (1) | WO2001005393A2 (de) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7235537B2 (en) | 2002-03-13 | 2007-06-26 | Array Biopharma, Inc. | N3 alkylated benzimidazole derivatives as MEK inhibitors |
NZ535158A (en) | 2002-03-13 | 2007-06-29 | Array Biopharma Inc | N3 alkylated benzimidazole derivatives as MEK inhibitors |
US7144907B2 (en) | 2003-09-03 | 2006-12-05 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
US7538120B2 (en) | 2003-09-03 | 2009-05-26 | Array Biopharma Inc. | Method of treating inflammatory diseases |
ATE472534T1 (de) | 2003-09-22 | 2010-07-15 | S | Benzimidazolderivate: herstellung und pharmazeutische anwendungen |
AU2004283148A1 (en) | 2003-10-21 | 2005-05-06 | Warner-Lambert Company Llc | Polymorphic form of N-[(R)-2,3-Dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide |
EP1529951A1 (de) | 2003-11-06 | 2005-05-11 | Gaveco AB | Verfahren und System für die automatische Abschaltung der Brennstoffzufuhr |
US7732616B2 (en) | 2003-11-19 | 2010-06-08 | Array Biopharma Inc. | Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof |
WO2005051906A2 (en) | 2003-11-19 | 2005-06-09 | Array Biopharma Inc. | Heterocyclic inhibitors of mek and methods of use thereof |
US7517994B2 (en) | 2003-11-19 | 2009-04-14 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
CN1882347A (zh) | 2003-11-21 | 2006-12-20 | 阿雷生物药品公司 | Akt蛋白激酶抑制剂 |
US7378423B2 (en) | 2004-06-11 | 2008-05-27 | Japan Tobacco Inc. | Pyrimidine compound and medical use thereof |
PL2298768T3 (pl) | 2004-06-11 | 2013-03-29 | Japan Tobacco Inc | Pochodne 5-amino-2,4,7-triokso-3,4,7,8-tetrahydro-2H-pirydo[2,3-d]pirymidyny i związki pokrewne do leczenia nowotworu |
US8299076B2 (en) | 2005-05-18 | 2012-10-30 | Array Biopharma Inc. | Crystalline forms of 2-(2-flouro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide |
BRPI0611993B1 (pt) | 2005-06-23 | 2023-11-28 | Array Biopharma, Inc. | Compostos de benzimidazol e seu processo de preparação |
JP5129143B2 (ja) | 2005-10-07 | 2013-01-23 | エグゼリクシス, インコーポレイテッド | Mekインヒビターおよびその使用方法 |
JP5116245B2 (ja) * | 2006-03-24 | 2013-01-09 | 地方独立行政法人 東京都立産業技術研究センター | 自動分析装置に用いる検量線作成用化合物 |
CA2656618C (en) | 2006-07-06 | 2014-08-26 | Array Biopharma Inc. | Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
US8063050B2 (en) | 2006-07-06 | 2011-11-22 | Array Biopharma Inc. | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
CN101511842B (zh) | 2006-07-06 | 2012-10-31 | 阵列生物制药公司 | 作为akt蛋白激酶抑制剂的二氢呋喃并嘧啶 |
EP2054418B1 (de) | 2006-07-06 | 2011-11-09 | Array Biopharma Inc. | Dihydrothienopyrimidine als akt-proteinkinase-inhibitoren |
CN101605540A (zh) | 2006-12-14 | 2009-12-16 | 埃克塞利希斯股份有限公司 | 使用mek抑制剂的方法 |
US9409886B2 (en) | 2007-07-05 | 2016-08-09 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
US8846683B2 (en) | 2007-07-05 | 2014-09-30 | Array Biopharma, Inc. | Pyrimidyl cyclopentanes as Akt protein kinase inhibitors |
ES2551352T3 (es) | 2007-07-05 | 2015-11-18 | Array Biopharma, Inc. | Pirimido ciclopentanos útiles para el tratamiento de enfermedades inflamatorias o hiperproliferativas |
KR20150091196A (ko) | 2007-07-05 | 2015-08-07 | 어레이 바이오파마 인크. | Akt 단백질 키나제 억제제로서의 피리미딜 시클로펜탄 |
GB0723794D0 (en) | 2007-12-05 | 2008-01-16 | Lectus Therapeutics Ltd | Potassium ion channel modulators and uses thereof |
MX2010007546A (es) | 2008-01-09 | 2010-09-30 | Array Biopharma Inc | Pirimidil ciclopentanos hidroxilados en forma de inhibidores de akt proteína quinasa. |
CN101932564B (zh) | 2008-01-09 | 2012-12-26 | 阵列生物制药公司 | 作为akt蛋白激酶抑制剂的羟基化嘧啶基环戊烷类 |
EP2346818B1 (de) | 2008-11-10 | 2012-12-05 | Bayer Intellectual Property GmbH | Substituierte sulfonamidophenoxybenzamide |
CN102574782B (zh) | 2009-10-21 | 2014-10-08 | 拜耳知识产权有限责任公司 | 取代的卤代苯氧基苯甲酰胺衍生物 |
US20120269803A1 (en) | 2009-10-21 | 2012-10-25 | Bayer Intellectual Property Gmbh | Substituted benzosulphonamides |
WO2011047788A1 (en) | 2009-10-21 | 2011-04-28 | Bayer Schering Pharma Aktiengesellschaft | Substituted benzosulphonamides |
EP2590957B1 (de) | 2010-07-09 | 2014-11-12 | Pfizer Limited | N-sulfonylbenzamide als inhibitoren von spannungsabhängigen natriumkanälen |
EP2632899A1 (de) | 2010-10-29 | 2013-09-04 | Bayer Intellectual Property GmbH | Substituierte phenoxypyridine |
CN103635192B (zh) | 2011-04-01 | 2017-07-04 | 基因泰克公司 | Akt抑制剂化合物和化疗剂的组合以及使用方法 |
JP6147246B2 (ja) | 2011-04-01 | 2017-06-14 | ジェネンテック, インコーポレイテッド | Akt及びmek阻害剤化合物の組み合わせ、及び使用方法 |
SI2909188T1 (en) | 2012-10-12 | 2018-07-31 | Exelixis, Inc. | A novel process for the manufacture of compounds for use in the treatment of cancer |
AR108257A1 (es) | 2016-05-02 | 2018-08-01 | Mei Pharma Inc | Formas polimórficas de 3-[2-butil-1-(2-dietilamino-etil)-1h-bencimidazol-5-il]-n-hidroxi-acrilamida y usos de las mismas |
JP6938545B2 (ja) | 2016-05-20 | 2021-09-22 | ゼノン・ファーマシューティカルズ・インコーポレイテッドXenon Pharmaceuticals Inc. | ベンゼンスルホンアミド化合物および治療剤としてのそれらの使用 |
KR20190086772A (ko) | 2016-12-09 | 2019-07-23 | 제논 파마슈티칼스 인크. | 벤젠술폰아미드 화합물 및 치료제로서의 그의 용도 |
EP3590920A4 (de) * | 2017-03-02 | 2021-01-06 | Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 2-(substituierte benzolmatrix)-aromatischer format-fto-inhibitor, herstellungsverfahren dafür und anwendungen davon |
WO2019241533A1 (en) | 2018-06-13 | 2019-12-19 | Xenon Pharmaceuticals Inc. | Benzenesulfonamide compounds and their use as therapeutic agents |
US10752623B2 (en) | 2018-08-31 | 2020-08-25 | Xenon Pharmaceuticals Inc. | Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors |
EP3844150A1 (de) | 2018-08-31 | 2021-07-07 | Xenon Pharmaceuticals Inc. | Heteroarylsubstituierte sulfonamidverbindungen und ihre verwendung als therapeutische mittel |
EP4370506A1 (de) | 2021-12-30 | 2024-05-22 | Biomea Fusion, Inc. | Pyrazinverbindungen als flt3-hemmer |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL62219C (de) * | 1945-05-07 | |||
US5155110A (en) * | 1987-10-27 | 1992-10-13 | Warner-Lambert Company | Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition |
JP2773836B2 (ja) * | 1988-07-12 | 1998-07-09 | 富士通株式会社 | 集積回路用レイアウト配線のネット抽出方法 |
US6251943B1 (en) * | 1997-02-28 | 2001-06-26 | Warner-Lambert Company | Method of treating or preventing septic shock by administering a MEK inhibitor |
EP0993437B1 (de) * | 1997-07-01 | 2006-11-08 | Warner-Lambert Company Llc | 2-(4-brom or 4-iod phenylamino)benzoesäurederivate und ihre anwendung als mek-inhibitoren |
CA2348236A1 (en) * | 1999-01-13 | 2000-07-20 | Stephen Douglas Barrett | 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
JP2002534446A (ja) * | 1999-01-13 | 2002-10-15 | ワーナー−ランバート・カンパニー | 4′ヘテロアリールジアリールアミン |
ES2252996T3 (es) * | 1999-01-13 | 2006-05-16 | Warner-Lambert Company Llc | Derivados de bencenosulfonamida y su uso como inhibidores de mek. |
ATE311363T1 (de) * | 1999-01-13 | 2005-12-15 | Warner Lambert Co | Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren |
-
2000
- 2000-07-05 WO PCT/US2000/018348 patent/WO2001005393A2/en active IP Right Grant
- 2000-07-05 IL IL14761800A patent/IL147618A0/xx unknown
- 2000-07-05 CN CN00809583A patent/CN1365277A/zh active Pending
- 2000-07-05 DE DE60005688T patent/DE60005688T2/de not_active Expired - Fee Related
- 2000-07-05 PL PL00352712A patent/PL352712A1/xx not_active Application Discontinuation
- 2000-07-05 TR TR2002/00205T patent/TR200200205T2/xx unknown
- 2000-07-05 ES ES00945140T patent/ES2208364T3/es not_active Expired - Lifetime
- 2000-07-05 PT PT00945140T patent/PT1202724E/pt unknown
- 2000-07-05 HU HU0202180A patent/HUP0202180A3/hu unknown
- 2000-07-05 EP EP00945140A patent/EP1202724B1/de not_active Expired - Lifetime
- 2000-07-05 AT AT00945140T patent/ATE250932T1/de not_active IP Right Cessation
- 2000-07-05 JP JP2001510450A patent/JP2003504401A/ja active Pending
- 2000-07-05 KR KR1020027000632A patent/KR20020016899A/ko not_active Application Discontinuation
- 2000-07-05 CA CA002378381A patent/CA2378381A1/en not_active Abandoned
- 2000-07-05 DK DK00945140T patent/DK1202724T3/da active
- 2000-07-05 AU AU59125/00A patent/AU5912500A/en not_active Abandoned
-
2003
- 2003-01-07 HK HK03100164.7A patent/HK1047895A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
KR20020016899A (ko) | 2002-03-06 |
PT1202724E (pt) | 2004-02-27 |
TR200200205T2 (tr) | 2002-06-21 |
ES2208364T3 (es) | 2004-06-16 |
WO2001005393A2 (en) | 2001-01-25 |
CN1365277A (zh) | 2002-08-21 |
HK1047895A1 (zh) | 2003-03-14 |
DE60005688D1 (de) | 2003-11-06 |
HUP0202180A3 (en) | 2004-10-28 |
CA2378381A1 (en) | 2001-01-25 |
AU5912500A (en) | 2001-02-05 |
DE60005688T2 (de) | 2004-04-29 |
PL352712A1 (en) | 2003-09-08 |
HUP0202180A2 (en) | 2002-10-28 |
DK1202724T3 (da) | 2004-01-26 |
WO2001005393A3 (en) | 2001-05-10 |
IL147618A0 (en) | 2002-08-14 |
EP1202724A2 (de) | 2002-05-08 |
EP1202724B1 (de) | 2003-10-01 |
JP2003504401A (ja) | 2003-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE250932T1 (de) | Verfahren zur behandlung von chronischem schmerz durch verabreichung von einem mek hemmer | |
ATE276753T1 (de) | Verfahren zur hemmung der krebsmetastasierung durch orale verabreichung von löslichem modifiziertem zitruspektin | |
TR200200082T2 (tr) | MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi. | |
DE69815090D1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
DE69924641D1 (de) | Behandlung von asthma anhand von mek-inhibitoren | |
DE69636096D1 (de) | Verfahren zur behandlung von gefässrestenose durch inhalieren von stickoxid | |
DE60120520D1 (de) | Verfahren zur behandlung von abwasser | |
ATE521357T1 (de) | Verfahren zur behandlung von hepatitis | |
DE69833971D1 (de) | Verfahren zur behandlung von alzheimerschen krankheit | |
WO2005000194A3 (en) | Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same | |
ATE437653T1 (de) | Verfahren zur behandlung von erkrankungen mit hsp90-hemmenden mitteln in kombination mit antimitotika | |
ATE430572T1 (de) | Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie | |
DE60310400D1 (de) | Botulinustoxine zur behandlung von priapismus | |
ATE382346T1 (de) | Verfahren zur behandlung von krankheiten mit hsp90-hemmenden mitteln in kombination mit antimetaboliten | |
ATE332688T1 (de) | Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung | |
DE602004022423D1 (de) | Hemmung der s6-kinase-aktivität zur behandlung von insulinresistenz | |
DE602004020971D1 (de) | Schlammbehandlung | |
ATE431157T1 (de) | Verfahren zur behandlung von durch taxol induzierter sensorischer neuropathie | |
ATE291434T1 (de) | Verwendung von angiotensin zur behandlung von krebsmetastasierung | |
DE59203616D1 (de) | Vorrichtung zur Behandlung von Oberflächen durch Sprühentladungen. | |
ATE225660T1 (de) | Verfahren zur verwendung von cyclooxygenase-2 hemmern zur behandlung und vorbeugung der demenz | |
ATE260741T1 (de) | Verfahren zur behandlung eines harzenthaltenden holzes | |
DE60112593D1 (de) | Verfahren zur racematspaltung von 2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazol sowie verbindungen dafür | |
DE60131568D1 (de) | Verfahren zur behandlung von entzündlichen stuhlgangsyndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1202724 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |